| Literature DB >> 28432334 |
Chaoyue Liu1,2,3, Anchun Cheng4,5,6, Mingshu Wang7,8,9, Shun Chen1,2,3, Renyong Jia1,2,3, Dekang Zhu2,3, Mafeng Liu1,2,3, Kunfeng Sun1,2,3, Qiao Yang1,2,3, Ying Wu1,2,3, Xinxin Zhao1,2,3, Xiaoyue Chen2,3.
Abstract
Duck enteritis virus (DEV) UL54 is a homologue of human herpes simplex virus-1 (HSV-1) ICP27, which plays essential regulatory roles during infection. Our previous studies indicated that DEV UL54 is an immediate-early protein that can shuttle between the nucleus and the cytoplasm. In the present study, we found that UL54-deleted DEV (DEV-ΔUL54) exhibits growth kinetics, a plaque size and a viral DNA copy number that are significantly different from those of its parent wild-type virus (DEV-LoxP) and the revertant (DEV-ΔUL54 (Revertant)). Relative viral mRNA levels, reflecting gene expression, the transcription phase and the translation stage, are also significantly different between DEV-ΔUL54-infected cells and DEV-LoxP/DEV-ΔUL54 (Revertant)-infected cells. However, the localization pattern of UL30 mRNA is obviously changed in DEV-ΔUL54-infected cells. These findings suggest that DEV UL54 is important for virus growth and may regulate viral gene expression during transcription, mRNA export and translation.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28432334 PMCID: PMC5430722 DOI: 10.1038/s41598-017-01161-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Construction of DEV-ΔUL54 and DEV-ΔUL54 (Revertant). (A) Construction of DEV-ΔUL54 and DEV-ΔUL54 (Revertant). The DEV CHv-BAC-ΔUL54 and DEV CHv-BAC-ΔUL54 (Revertant) were constructed with the Red recombinant system and rescued in DEFs cells. Using the Cre-LoxP system, the BAC-EGFP tag was removed. (B) Identification of DEV-ΔUL54 and DEV-ΔUL54 (Revertant) by PCR. M: DL15000; 1: DEV CHv-BAC-ΔUL54; 2: DEV-ΔUL54; 3: DEV-ΔUL54 (Revertant); 4: DEV CHv-BAC-ΔUL54 (Revertant). The target fragment size in DEV CHv-BAC-ΔUL54/DEV CHv-BAC-ΔUL54 (Revertant) was approximately 10000 bp, and it was nearly 1700 bp for DEV-ΔUL54/DEV-ΔUL54 (Revertant). (C) Identification of DEV-ΔUL54 and DEV-ΔUL54 (Revertant) by IFA. DEFs cells that were infected with DEV-ΔUL54 or DEV-ΔUL54 (Revertant) were subjected to IFA with Anti-UL54 polyclonal antibody as a primary antibody; DEV-ΔUL54 treated with Anti-UL13 polyclonal antibody as primary antibody was used as a control. (D) Identification of DEV-ΔUL54 and DEV-ΔUL54 (Revertant) by Western blot. Proteins of DEFs cells infected with DEV-ΔUL54 or DEV-ΔUL54 (Revertant) were subjected to Western blot with Anti-UL54 polyclonal antibody as a primary antibody. 1: DEV-ΔUL54 (Revertant); 2: DEV-ΔUL54; 3: DEV-ΔUL54 subjected with Anti-UL13 polyclonal antibody as a primary antibody.
Figure 2Growth curve and plaque size of the DEV-derived viruses. (A) Growth curve. DEFs were infected with DEV-LoxP, DEV-ΔUL54 or DEV-ΔUL54 (Revertant) at a titer of 200 TCID50 and harvested at different time points. The curve was generated based on the titers of different harvests by testing TCID50. a: p < 0.05. (B) Phenotypes of viral plaques. Plaques were formed on DEFs under a semi-solid medium overlay containing methylcellulose. After fixation, crystal violet staining was performed. (C) Analysis of the plaque area. The mean areas of plaque were analyzed using IPP 6.0. **p < 0.01.
Figure 3Viral DNA copy number of the DEV-derived viruses. (A) Construction of the standard curve. (B) Levels of DEV-derived genomic DNA. DEFs were infected with DEV-LoxP, DEV-ΔUL54 or DEV-ΔUL54 (Revertant) at 200 TCID50. At different time points, total viral DNA was purified, and quantitative PCR was performed. **p < 0.01.
Figure 4Effects of DEV UL54 on viral mRNA expression. DEFs were infected with DEV-LoxP, DEV-ΔUL54 or DEV-ΔUL54 (Revertant) at 200 TCID50, and RT-PCR was performed to assess the relative expression levels of UL19, UL30, UL48, gC, gD and gK at different time points. *p < 0.05; **p < 0.01.
Figure 5Regulation of DEV UL54 on viral gene transcription. DEFs were infected with DEV-LoxP, DEV-ΔUL54 or DEV-ΔUL54 (Revertant) at 200 TCID50 and the nuclei were extracted. After a nuclear run-off assay, RT-PCR was performed to assess the relative transcriptional mRNA levels of UL19, UL30, UL48, gC, gD and gK at different time points. *p < 0.05; **p < 0.01.
Figure 6Regulation of DEV UL54 on viral gene translation. DEFs were infected with DEV-LoxP, DEV-ΔUL54 or DEV-ΔUL54 (Revertant) at 400 TCID50. After extracting RNC, RT-PCR was performed to assess the relative translational mRNA levels of UL19, UL30, UL48, gC, gD and gK at different time points. *p < 0.05; **p < 0.01.
Figure 7Effect of DEV UL54 on the export of UL30 mRNA. DEFs were infected with DEV-LoxP, DEV-ΔUL54 or DEV-ΔUL54 (Revertant) at 200 TCID50 and subjected to a FISH assay to visualize the localization of UL30 mRNA.
Primers for real-time PCR.
| Primer name | Sequence(5′-3′) | Size (bp) |
|---|---|---|
| β-actin(F) | CCGGGCATCGCTGACA | 177 |
| β-actin(R) | GGATTCATCATACTCCTGCTTGCT | |
| UL19(F) | TCTATACGAAGCACAGATGGAC | 92 |
| UL19(R) | ATGCAACAGAAAGACCCAA | |
| UL30(F) | GAGAAAAGCAATACGAGCCAAGA | 121 |
| UL30(R) | ACTCACTCCACAGAACCCATACAC | |
| UL48(F) | TGCCTGTCATACGTTGTG | 134 |
| UL48(R) | AATACGCTTCCATCTTGC | |
| gC(F) | GAATAAACAACCGGAACTGCT | 132 |
| gC(R) | GTCTTTGATCGGTTCGCTTC | |
| gD(F) | TGGTTCAAAGTCGGAGTGGG | 168 |
| gD(R) | AATGACCAGTCCGAGTTCGT | |
| gK(F) | CGTATTGTATCTGCGGCT | 164 |
| gK(R) | CGAGTGGGCGAAATGAAC |